Shopping Cart
Remove All
Your shopping cart is currently empty
AR20.5
Catalog No. T9901A-991 Copy Product Info
🥰Excellent
AR20.5 represents a highly specialized murine monoclonal antibody specifically engineered to target the tumor-associated antigen MUC1 with exceptional binding affinity. It effectively facilitates the measurable induction of antigen-specific T-cell immune responses across various preclinical experimental models to evaluate the synergy between antibody-mediated vaccination and immune checkpoint blockade during strictly monitored laboratory observation periods and functional tumor challenge assays.
AR20.5
Copy Product Info🥰Excellent
Catalog No. T9901A-991
AR20.5 represents a highly specialized murine monoclonal antibody specifically engineered to target the tumor-associated antigen MUC1 with exceptional binding affinity. It effectively facilitates the measurable induction of antigen-specific T-cell immune responses across various preclinical experimental models to evaluate the synergy between antibody-mediated vaccination and immune checkpoint blockade during strictly monitored laboratory observation periods and functional tumor challenge assays.
AR20.5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | AR20.5 represents a highly specialized murine monoclonal antibody specifically engineered to target the tumor-associated antigen MUC1 with exceptional binding affinity. It effectively facilitates the measurable induction of antigen-specific T-cell immune responses across various preclinical experimental models to evaluate the synergy between antibody-mediated vaccination and immune checkpoint blockade during strictly monitored laboratory observation periods and functional tumor challenge assays. |
| In vitro | In MUC1-expressing pancreatic cancer cells, AR20.5 enhanced T cell-mediated cytotoxicity and increased IFN-gamma production when combined with PD-L1 blockade [1]. |
| In vivo | In MUC1.Tg mice challenged with pancreatic tumors, the combination of AR20.5 and anti-PD-L1 significantly inhibited tumor progression and prolonged survival [1]. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | MUC1 |
| Isotype | IgG1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy AR20.5 | purchase AR20.5 | AR20.5 cost | order AR20.5 | AR20.5 in vivo | AR20.5 in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.